Literature DB >> 12203262

In vitro activity of Triclisia patens and some bisbenzylisoquinoline alkaloids against Leishmania donovani and Trypanosoma brucei brucei.

Maria del Rayo Camacho1, J David Phillipson, Simon L Croft, Peter Rock, Sarah J Marshall, Paul L Schiff.   

Abstract

In the search for antiprotozoal compounds from natural sources, Triclisia patens displayed activity against L. donovani promastigotes (IC(50) = 1.5 microg/mL) and T. b. brucei blood stream trypomastigote forms (IC(50) = 31.25 microg/mL). In addition, a total of 20 bisbenzylisoquinoline alkaloids were screened for antileishmanial and antitrypanosomal activity in vitro. Fangchinoline (IC(50) = 0.39 microM) was found to be as active as the standard pentamidine against Leishmania donovani promastigotes. Phaeanthine was three-fold more active (IC(50) = 2.41 microM; 1.5 microg/mL) than the standard drug Pentostam against L. donovani amastigotes, but at this concentration was toxic to murine macrophages. In contrast, cocsoline (IC(50) = 12.3 microM; 6.76 microg/mL) was as active as Pentostam, and was not toxic to macrophages at this concentration. Thalisopidine showed the strongest activity (IC(50) = 1.14 microM) against Trypanosoma brucei brucei blood stream form trypomastigotes, but was less active than pentamidine. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203262     DOI: 10.1002/ptr.929

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  7 in total

1.  Novel compounds active against Leishmania major.

Authors:  Stephanie St George; Jeanette V Bishop; Richard G Titus; Claude P Selitrennikoff
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Northalrugosidine is a bisbenzyltetrahydroisoquinoline alkaloid from Thalictrum alpinum with in vivo antileishmanial activity.

Authors:  C Benjamin Naman; Gaurav Gupta; Sanjay Varikuti; Heebyung Chai; Raymond W Doskotch; Abhay R Satoskar; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2015-01-28       Impact factor: 4.050

3.  In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.

Authors:  Marieke Vermeersch; Raquel Inocêncio da Luz; Kim Toté; Jean-Pierre Timmermans; Paul Cos; Louis Maes
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

4.  Post-translational import of protein into the endoplasmic reticulum of a trypanosome: an in vitro system for discovery of anti-trypanosomal chemical entities.

Authors:  Bhargavi Patham; Josh Duffy; Ariel Lane; Richard C Davis; Peter Wipf; Sheara W Fewell; Jeffrey L Brodsky; Kojo Mensa-Wilmot
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

5.  Isoquinolines from the roots of Thalictrum flavum L. and their evaluation as antiparasitic compounds.

Authors:  Jacqueline Ropivia; Séverine Derbré; Caroline Rouger; Fabrice Pagniez; Patrice Le Pape; Pascal Richomme
Journal:  Molecules       Date:  2010-09-16       Impact factor: 4.411

6.  Steroid Alkaloids from Holarrhena africana with Strong Activity against Trypanosoma brucei rhodesiense.

Authors:  Charles Okeke Nnadi; Ngozi Justina Nwodo; Marcel Kaiser; Reto Brun; Thomas J Schmidt
Journal:  Molecules       Date:  2017-07-06       Impact factor: 4.411

7.  Comparative molecular docking of antitrypanosomal natural products into multiple Trypanosoma brucei drug targets.

Authors:  Ifedayo V Ogungbe; William N Setzer
Journal:  Molecules       Date:  2009-04-14       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.